New
Mexico Register / Volume XXXVI, Issue 10 / May 20, 2025
This is an
amendment to 1.7.8 NMAC, Sections 8, 9, 10, 13, 15 and 18, effective 5/20/2025.
1.7.8.8 OMNIBUS TRANSPORTATION
EMPLOYEE TESTING ACT OF 1991:
A. Employees in safety-sensitive positions within the meaning of the Omnibus
Transportation Employee Testing Act of 1991 ("Omnibus Act" (49 U.S.C. Subtitle VI Part B § 31306) are
exempt from and are not covered by the provisions of 1.7.8.7 NMAC and 1.7.8.9 NMAC through [1.7.8.20] 1.7.8.19
NMAC.
B. Agencies with employees covered by the Omnibus Act shall develop and
submit to the state personnel office (SPO) director a policy for implementing
drug and alcohol tests.
C. The policy shall contain at the least the:
(1) covered positions;
(2) testing requirements for drugs and alcohol;
(3) collection of specimen;
(4) reporting and explanation of test results;
(5) confidentiality;
(6) training;
(7) rehabilitation and sanctions;
(8) record retention;
(9) rehabilitative and sanction
parameters of drug and alcohol abuse; and
(10) reasonable
suspicion.
D. Agencies shall
advise the board annually of those positions covered by the Omnibus Act.
[1.7.8.8 NMAC - Rp,
1.7.8.8 NMAC, 1/14/2025; A, 5/20/2025]
1.7.8.9 SUBSTANCE ABUSE COORDINATOR:
A. Each agency shall appoint a substance abuse coordinator who shall be
responsible for the agency's drug and alcohol abuse program.
B. The substance abuse coordinator shall provide drug and alcohol abuse
awareness information to employees including but not limited to the:
(1) dangers of drug and alcohol abuse;
(2) availability of counseling, rehabilitation, and employee assistance
programs; and
(3) sanctions that may be imposed upon employees as provided in [1.7.8.19] 1.7.1.18 NMAC.
C. The drug abuse coordinator shall ensure that the agency has contracted
or made arrangements with a medical review officer to
perform the duties required by 1.7.8 NMAC.
[1.7.8.9 NMAC – Rp
& Rn., 1.7.8.10 NMAC, 1/14/2025; A, 5/20/2025]
1.7.8.10 AUTHORIZED
DRUG AND ALCOHOL TESTING:
A. The SPO director shall maintain a
list of positions designated by the agencies as being safety-sensitive.
B. All candidates for safety-sensitive positions are required to submit to
drug testing after an offer of employment is made and prior to final selection.
C. Agencies that require employees in safety-sensitive positions to
undergo regular physical examinations shall require such employees to undergo
drug testing as part of those physical examinations.
D. Agencies
shall require employees to undergo drug, alcohol testing or both if the agency
has a reasonable suspicion that the employee has committed drug or alcohol
abuse based on, but not limited to:
(1) direct observation of the physical symptoms or manifestations of being
under the influence of a drug or alcohol while on duty; such symptoms may
include, but are not limited to liquor on breath, slurred speech, unsteady
walk, or impaired coordination; or
(2) direct observation of the use or possession of drugs or drug
paraphernalia, or the use of alcohol while on duty.
E. An employee shall submit to a reasonable suspicion drug
or alcohol test provided the requesting supervisor has
secured the next level supervisor’s approval, unless the requesting supervisor
is the agency head. The requesting supervisor shall
prepare a contemporaneous memorandum outlining the details leading up to the
reasonable suspicion drug or alcohol test. The memorandum shall be submitted to
the substance abuse coordinator within 24 hours of the request for testing.
F At
least ten percent of employees in safety-sensitive positions in each agency
shall be required to undergo drug testing on a yearly basis.
(1) The SPO director shall identify the safety-sensitive positions on a
random selection basis.
(2) At the discretion of the agency head or substance abuse coordinator,
employees may be excused from random drug testing if:
(a) they have previously requested referral in accordance with the
provisions of Subsection
B of [1.7.8.19] 1.7.1.18
NMAC;
(b) the selection for random drug testing is made during the first 30
calendar days following the request for referral; or
(c) they
are on an authorized absence for 30 calendar days or more.
(3) The
agency head or substance abuse coordinator shall inform the SPO director of any
employee excused from random drug testing within 10 working days of receipt of
the notice of safety sensitive testing.
G. The SPO director may authorize an agency to conduct more
than ten percent (10%) random drug testing on employees in safety sensitive
positions upon receipt of an agency’s written request that would include
justification of how the additional testing is related to the conditions of
employment and the use of equipment that could pose a risk to public health or
safety.
[1.7.8.10 NMAC – Rp
& Rn., 1.7.8.11 NMAC, 1/14/2025; A, 5/20/2025]
1.7.8.13 ALCOHOL
TESTS:
A. A
test for alcohol shall be administered by a legally recognized and approved
method.
B. A
test by a legally recognized or approved method with results of blood alcohol
content (BAC) level of .04 or more shall be deemed positive for alcohol.
C. For
employees who have undergone alcohol rehabilitation, pursuant to Paragraph (1) of
Subsection D of [1.7.8.19] 1.7.1.18
NMAC, a positive test result during the 30 to 180 calendar days
following the first positive test shall subject an employee to disciplinary
action. Such a test may be performed by
urinalysis.
[1.7.8.13 NMAC - Rp,
1.7.8.14 NMAC, 1/14/2025; A, 5/20/2025]
1.7.8.15 EXPLANATION
OF POSITIVE TEST RESULTS:
A. Candidates
for a safety sensitive position who test positive for drugs, alcohol or both may,
within two workdays of being advised of the test results, submit a written
request to the agency's substance abuse coordinator for a review of the test
results by the medical review officer. The test results of all employees who
test positive for drugs, alcohol or both shall be referred by the agency's
substance abuse coordinator or designee to the medical review officer.
(1) If the candidate does not request a review of the test results within
two workdays, the candidate waives review by the medical review officer and any
retesting of the sample and consents to rejection for selection.
(2) The medical review officer shall examine any proffered or possible
explanations concerning the validity of the confirmed positive test results.
This action may include conducting a medical interview, review of the medical
history, review of the chain of custody, and discussions with the collection or
laboratory personnel. The medical review officer shall review all medical
records made available by the individual when a positive test could have
resulted from legally prescribed medications for medical or dental treatment.
The medical review officer shall also review the results of any retest done
according to the provisions of [1.7.8.17] 1.7.1.16 NMAC.
(a) Should any questions arise as to the accuracy or validity of a
confirmed positive test result, only the medical review officer is authorized
on behalf of the state to order a reanalysis of the original sample and such
retests are authorized to be performed only at a laboratory that meets
applicable provisions of any state licensure requirements and is certified by
the substance abuse and mental health services administration or the college of
American pathologists in forensic urine drug testing.
(b) Prior to making a final decision to verify a positive test result, the
medical review officer shall give the candidate or employee an opportunity to
discuss the test results. The discussion between the medical review officer and
the candidate or employee may be in person or by telephone.
(c) The medical review officer shall advise the appropriate substance abuse
coordinator of his or her medical conclusions from the review of the test
results. If there are conflicting factual statements, the medical review
officer shall not attempt to resolve that factual conflict,
but shall report it along with his or her medical conclusions to the
agency substance abuse coordinator. Similarly, the medical review officer shall
not attempt to ascertain the factual correctness of any claim by the candidate
or employee of involuntary ingestion of drugs or alcohol or both,
but shall simply report such claims to the agency substance abuse
coordinator with his or her medical opinion as to the possibility that such
occurrence could have affected the test results.
B. Based
upon the medical review officer's report and such other inquiries or facts as
the agency may consider, the agency shall determine whether the explanations or
challenges of the confirmed positive test results are satisfactory.
(1) If the explanations or challenges of the positive test results are
unsatisfactory the agency:
(a) shall
provide a written explanation to the candidate or employee as to why the
explanation is unsatisfactory, along with the test results, within 11 calendar
days of the agency's determination; and
(b) shall
retain such records as confidential for one year.
(2) If the explanations or challenges of the positive test results are
satisfactory the agency:
(a) shall notify the candidate or employee in writing within 11 calendar
days of the agency's determination; and
(b) shall
retain such records as confidential for one year.
[1.7.8.15 NMAC – Rp
& Rn., 1.7.8.16 NMAC, 1/14/2025; A, 5/20/2025]
1.7.8.18 REHABILITATION
AND SANCTIONS:
A. Candidates for employment:
(1) A candidate for employment in a safety-sensitive position shall be
rejected for selection when he tests positive for drugs and does not seek
review by the medical review officer or cannot satisfactorily explain the
positive test results.
(2) An employee for transfer or promotion to a safety-sensitive position
who tests positive for drugs and is unable to satisfactorily explain the
positive test results shall be subject to disciplinary action including
dismissal if the employee occupies a safety-sensitive position. If the employee is not in a safety-sensitive
position, the employee shall be treated in accordance with the provisions of Subsection D of
[1.7.8.19] 1.7.1.18
NMAC.
B. Voluntary self-identification by
employees:
(1) Any employee who requests referral to an EAP, counseling or a drug or
alcohol rehabilitation program, prior to selection for drug and alcohol testing
shall be referred by the substance abuse counselor. Any costs for counseling or rehabilitation
shall be borne by the employee.
(2) The agency may grant administrative leave to an employee to participate
in an employee assistance program, counseling, or a drug or alcohol
rehabilitation program for up to 240 hours for the initial voluntary
self-identification only.
(3) Employees in safety-sensitive positions, who have requested referral
shall be assigned to non safety-sensitive duties
until successful completion of the approved substance abuse program or
treatment plan and release by the substance abuse program provider.
(4) Employees are subject to drug, alcohol testing or both at the
discretion of the substance abuse coordinator at any time between 30 and 180
calendar days of requesting referral.
(a) Employees in safety-sensitive positions who test positive during this time period or fail to successfully complete such program
are subject to disciplinary action including dismissal.
(b) Employees in non safety-sensitive positions
who test positive during this time period or fail to
successfully complete such program may be subject to disciplinary action
including dismissal. The agency may
allow the employee to use annual leave, sick leave, or leave without pay for
additional counseling or rehabilitation by the agency after considering all
factors relevant to the employee's condition and job performance history.
(5) For employees who have been required to undergo an alcohol
rehabilitation program, any indication of alcohol at any level during the 30 to
180 calendar day period following the referral shall be considered a positive
test result.
C. Safety-sensitive
positions: Employees in
safety-sensitive positions who have not requested referral to an employee
assistance program, counseling, or a drug or alcohol rehabilitation program and
test positive on a required drug, alcohol test or both shall be subject to
disciplinary action including dismissal if they do not have a satisfactory
explanation for the positive test results.
D. Non safety-sensitive
positions:
(1) Employees in non safety-sensitive positions
who test positive on a reasonable suspicion drug or alcohol test
or both required by Subsection [D] E of [1.7.8.11] 1.7.1.10 NMAC and do not have
a satisfactory explanation for the positive test results shall be referred to
an employee assistance program, counseling, or a drug or alcohol rehabilitation
program. Employees are subject to drug
or alcohol testing at the discretion of the substance abuse coordinator at any
time between 30 and 180 calendar days of the first positive test. Any such employee who tests positive for
drugs, alcohol or both between 30 and 180 calendar days of the first positive
test without a satisfactory explanation or who fails to enter and successfully
complete a program shall be subject to disciplinary action including dismissal.
(2) The agency may grant an employee administrative leave to participate in
an employee assistance program, counseling, or a drug or alcohol rehabilitation
program for up to 240 hours for the initial reasonable suspicion referral only.
E. Refusal to cooperate in testing
procedure: Any employee who refuses or fails without good
cause to cooperate in the drug or alcohol testing or both procedure by refusing
or failing to complete the specified forms, by refusing or failing to submit a
urine or breath specimen, or otherwise refuses or
fails to cooperate shall be subject to disciplinary action including dismissal.
F. Possession of drugs or alcohol:
(1) Employees who illegally sell, purchase, or convey from one person or
one place to another drugs or any substance in Schedules I and II of the
Controlled Substances Act, Sections 30-31-1 to 30-31-41 NMSA 1978 (Repl. Pamp. 1994),
while on duty shall be subject to disciplinary action including dismissal and
shall be reported to the local law enforcement agency.
(2) When employees, while on duty consume or have in their possession drugs,
open containers of alcohol or any substance in Schedules I and II of the
Controlled Substances Act, Sections
30-31-1 to 30-31-41 NMSA 1978 (Repl.
Pamp. 1994) without a valid prescription or as otherwise authorized by law,
they shall be subject to disciplinary action including dismissal and shall be
reported to the local law enforcement agency.
[1.7.8.18 NMAC – Rp
& Rn., 1.7.8.19 NMAC, 1/14/2025; A, 5/20/2025]